Gene amplification of DTYMK was more common in cancers such as ovarian serous cystadenocarcinoma (OV), uterine carcinosarcoma (UCS), pancreatic adenocarcinoma (PAAD), LUAD, thymoma (THYM), and LIHC (Figure 1C). Here, DTYMK is linked to cancer.